Macrophage Polarization States in the Tumor Microenvironment
Open accessThe DOI matches its Crossref record; 147 of the 148 references it cites were found in a registry or an index.
Abstract
The M1/M2 macrophage paradigm plays a key role in tumor progression. M1 macrophages are historically regarded as anti-tumor, while M2-polarized macrophages, commonly deemed tumor-associated macrophages (TAMs), are contributors to many pro-tumorigenic outcomes in cancer through angiogenic and lymphangiogenic regulation, immune suppression, hypoxia induction, tumor cell proliferation, and metastasis. The tumor microenvironment (TME) can influence macrophage recruitment and polarization, giving way to these pro-tumorigenic outcomes. Investigating TME-induced macrophage polarization is critical for further understanding of TAM-related pro-tumor outcomes and potential development of new therapeutic approaches. This review explores the current understanding of TME-induced macrophage polarization and the role of M2-polarized macrophages in promoting tumor progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies have shown that MSCs have the ability to polarize M1 pro-inflammatory macrophages towards an alternative M2 anti-inflammatory phenotype [21,22,23].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [21]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In addition, CD4+ T cells impact cancer immunology (30), M1 macrophages suppress tumors, and M2 macrophages aid tumor growth (31).”
From A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer (2025) · cites this paper as [31]
The cited source says what the claim attributes to it.
In the citing paper
“In addition, CD4+ T cells impact cancer immunology (30), M1 macrophages suppress tumors, and M2 macrophages aid tumor growth (31).”
From A multimodal and fully automated system for prediction of pathological complete response to neoadjuvant chemotherapy in breast cancer (2025) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 3×
“These CD8+ T and NK cells express high levels of cytokines such as IFN-γ, GM-CSF, and TNF-α as well as chemokines such as CCL4, CCL5, and CCL23 that assist in the further recruitment of immune cells and the signaling of anti-tumorigenic pathways [73,74].”
BackgroundMyeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · cited 2×
“MDSCs express high levels of both iNOS and arginase-1, which both play a direct role in suppression of T-cell function [95].”
BackgroundOrigin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · cited 1×
“Inflammation can be triggered by conditions such as infection or injury or can be systemic as seen in type 2 diabetes and cardiovascular disease [59].”
BackgroundMacrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 3×
“Current literature supports the theory that most TAMs originate from either tissueresident embryonic macrophages or macrophages derived from circulating monocytes that originate in the bone marrow [87].”
BackgroundMANTOVANI, A., SOZZANI, S., LOCATI, M., ALLAVENA, P., & SICA, A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02302-5 · Cited by 5,528 · cited 3×
“The significance of macrophage heterogeneity has been under review since the early 2000s and has been linked to many malignancies and autoimmune disorders in recent years [66].”
BackgroundProtective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 1×
“The resolution of inflammation is led by the deactivation of these inflammatory mediators, permitting either the apoptosis of pro-inflammatory M1 macrophages or the transition to an anti-inflammatory M2 macrophage [64].”
BackgroundMacrophage biology in development, homeostasis and disease
Wynn, T. A., Chawla, A., & Pollard, J. W. (2013) · Nature · doi:10.1038/nature12034 · Cited by 4,684 · cited 15×
“Macrophages are found in every human tissue in the body and exhibit anatomical and functional diversity [4].”
BackgroundInfluentialMurray, P. J. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034339 · Cited by 2,981 · cited 2×
“Some noncytokine, extrinsic pathways of macrophage polarization do exist, however, including hypoxia as well as the production of lactate within tumors, which drive M2 polarization [36].”
BackgroundFibroblast growth factor signalling: from development to cancer
Turner, N., & Grose, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2780 · Cited by 2,693
Cited by
Items 401–500 of 1,000
Xiong, B., Wang, H., Song, Y., Lan, W.-Y., Li, J., & Wang, F. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1584035 · Cited by 22
Wang, L., Zhou, D., & Ou, Y. (2025) · Current Proteomics · doi:10.1016/j.curpro.2025.100029 · Cited by 19
Zhang, Z., Yu, K., Cao, Y., Xie, P., Wang, L., Shen, Z., & Qin, J. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08198-4 · Cited by 24
“Macrophages are the most abundant immune cells in the TME, which greatly affect the homeostasis of the TME and the patient ’ s response to immunotherapy [9].”
Tumour‐derived exosomes in liver metastasis: A Pandora's box
Li, S., Qu, Y., Liu, L., Wang, C., Li, Y., Bai, H., & Wang, J. (2023) · Cell Proliferation · doi:10.1111/cpr.13452 · Cited by 23
“90,91 Recent studies showed that TDEs are closely associated with macrophage polarization, 92 – 95 and TDE-mediated macrophage phenotypic changes are key mediators during liver PMN establishment and maintenance.”
CCL2-Mediated Stromal Interactions Drive Macrophage Polarization to Increase Breast Tumorigenesis
Archer, M., Bernhardt, S. M., Hodson, L. J., Woolford, L., der Hoek, M. B. V., Dasari, P., Evdokiou, A., & Ingman, W. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087385 · Cited by 20
Chemoresistance in pancreatic ductal adenocarcinoma: Overcoming resistance to therapy
Bhoopathi, P., Mannangatti, P., Das, S. K., Fisher, P. B., & Emdad, L. (2023) · Advances in cancer research · doi:10.1016/bs.acr.2023.02.010 · Cited by 20
FBXO22 Mediates the NGF/TRKA Signaling Pathway in Bone Metastases in Prostate Cancer
Zhang, Y., Li, W., Guo, S., Wu, Z. Q., Zhang, L., Liu, Y., Li, X., Guo, X., Cao, J., Yang, C., et al. (2023) · American Journal Of Pathology · doi:10.1016/j.ajpath.2023.05.012 · Cited by 19
Chen, M., Cao, C., & Ma, J. (2023) · Thoracic Cancer · doi:10.1111/1759-7714.15182 · Cited by 20
“21,22 Many circRNAs have been shown to mediate cancer progression by affecting TAMs.”
BackgroundAdvances in Metabolic Regulation of Macrophage Polarization State
Liu, X., Xiang, R., Fang, X., Wang, G., & Zhou, Y. (2024) · Immunological Investigations · doi:10.1080/08820139.2024.2302828 · Cited by 21
“Cancer cells within the TME directly affect the polarization of TAMs, and phenotypic ratios significantly alter as cancer progresses (Boutilier & Elsawa, 2021; Ma et al., 2017; Nalio Ramos et al., 2022; Pan et al., 2020).”
BackgroundWhite, E. E., & Rhodes, S. D. (2024) · Cancers · doi:10.3390/cancers16050994 · Cited by 22
“Tumor-associated macrophages can differentiate along either M1 (pro-inflammatory/anti-tumorigenic) or M2 (anti-inflammatory/pro-tumorigenic) trajectories [103].”
BackgroundXie, C., Sun, Q., Chen, J., Yang, B., Lu, H., Liu, Z., Li, Y., Li, K., Tang, B. H., & Lin, L. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.132029 · Cited by 23
Li, J., Luo, X., Shiu, P. H.-T., Cheng, Y., Nie, X., Rangsinth, P., Lau, B. W. M., Zheng, C., Li, X., Li, R., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116901 · Cited by 19
Plant‐Derived Extracellular Vesicles as Potential Emerging Tools for Cancer Therapeutics
Ding, L., Chang, C., Liang, M., Dong, K., & Li, F. (2024) · Advanced Therapeutics · doi:10.1002/adtp.202400256 · Cited by 20
Zhang, X., Qian, S., Wu, P., Yu, B., Yin, D., Xia, P., Li, S., Xiao, Z., & Xie, Z. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01799-0 · Cited by 23
“The recruitment and functional polarization of TAMs in the TME is an extremely complex process that is regulated by various cytokines and environmental factors [22].”
BackgroundPotential mechanisms of rheumatoid arthritis therapy: Focus on macrophage polarization
Yang, X., Li, J., Xu, C., Zhang, G., Che, X., & Yang, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113058 · Cited by 22
Seo, J., Ha, G., Lee, G., Nasiri, R., & Lee, J. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.10.036 · Cited by 20
Exosomes and MicroRNAs: key modulators of macrophage polarization in sepsis pathophysiology
Saadh, M. J., Saeed, T. N., Alfarttoosi, K. H., Sanghvi, G. V., Roopashree, R., Thakur, V., Lakshmi, L., Kubaev, A., Taher, W. M., Alwan, M., et al. (2025) · European journal of medical research · doi:10.1186/s40001-025-02561-z · Cited by 21
“In addition, the M2 subtype has been associated with alternative activation and tissue healing in both species, suggesting possible treatment options for human diseases [94, 103–105].”
Wang, J., Jin, J., Chen, T., & Zhou, Q. (2022) · Molecules · doi:10.3390/molecules27144345 · Cited by 20
Ohya, S., Matsui, M., Kajikuri, J., Kito, H., & Endo, K. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158603 · Cited by 19
“In the TME, tumor-infiltrating, M2differentiated TAMs promote escape from cancer immune surveillance, thereby enhancing invasive and metastatic potentials and angiogenesis in cancer [1,2].”
BackgroundInfluentialWnt2b and Wnt5a expression is highly associated with M2 TAMs in non‑small cell lung cancer
Sumitomo, R., Huang, C., Ando, H., Ishida, T., Cho, H., & Date, H. (2022) · Oncology Reports · doi:10.3892/or.2022.8404 · Cited by 19
Xu, Y., Zhang, H., & Nie, D. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1521550 · Cited by 27
“Both M1 and M2 TAMs are present at all stages of tumor progression (11).”
Zhang, Z., & Wu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1641518 · Cited by 21
“M2-polarized TAMs, in particular, are central drivers of immunotherapy resistance in GI tumors, fostering an immunosuppressive milieu that blunts treatment ef fi cacy (26).”
Immune cell-based therapies for solid tumors, current challenges and therapeutic advances
Torabi, S., Yekzaman, E., Taherkhani, S., Talachi, N., Khoshravesh, R., Khosravi, A., Salehi, M., Zarrabi, A., & Vosough, M. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02632-y · Cited by 22
“The presence of TAM has been linked to tumor progression, metastasis, and resistance to therapy [27].”
Sung, Y., Kim, D. K., Kim, J. S., Kim, S.-J., Kim, J. H., & Han, J. M. (2026) · Experimental & Molecular Medicine · doi:10.1038/s12276-026-01697-0 · Cited by 22
“Distinct metabolic programs drive polarization toward M1 (antitumor) or M2 (protumor) phenotypes 141 .”
Chen, X., Wang, L., Yu, H., Shen, Q., Hou, Y., Xia, Y., Li, L., Chang, L., & Li, W. (2023) · Molecular Immunology · doi:10.1016/j.molimm.2023.01.009 · Cited by 21
Insights on hematopoietic cell kinase: An oncogenic player in human cancer
Luo, S., Du, S., Tao, M., Cao, J., & Cheng, P. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114339 · Cited by 18
Laeviganoids A–T, ent -Clerodane-Type Diterpenoids from Croton laevigatus
Wang, C.-L., Dai, Y., Zhu, Q., Xia, P., Liu, Q., Ai, J., Zhou, B., & Yue, J. (2023) · Journal of Natural Products · doi:10.1021/acs.jnatprod.3c00173 · Cited by 19
Pundkar, C. Y., Antony, F., Kang, X., Mishra, A., Babu, R. J., Chen, P., Li, F., & Suryawanshi, A. S. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16688 · Cited by 22
“These in vitro TME-conditioned macrophages acquire an immunosuppressive phenotype closely resembling in vivo TAMs compared to M2 macrophages generated or stimulated using IL-4/IL-10 [80, 81].”
BackgroundYu, Y., Hao, J., Wang, L., Zheng, X., Xie, C., Liu, H., Wu, J., Qiao, S., & Shi, J. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154766 · Cited by 20
Qin, J., Cui, Z., Zhou, J., Zhang, B., Lu, R., Ding, Y., Hu, H., & Cai, J. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101764 · Cited by 18
“M2-polarized macrophages, commonly considered TAMs, play a pro-tumor role in cancer through regulation [53].”
BackgroundJin, G., Chang, Y., & Bao, X. (2023) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2023.100409 · Cited by 20
“27”
Strachowska, M., Gronkowska, K., Sobczak, M., Grodzicka, M., Michlewska, S., Kołacz, K., Sarkar, T., Korszun, J., Йонов, М., & Robaszkiewicz, A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115798 · Cited by 19
Thipe, V. C., Jatar, A., Karikachery, A. R., Katti, K. K., & Katti, K. V. (2023) · Nanotechnology Science and Applications · doi:10.2147/nsa.s437812 · Cited by 21
Macrophages and angiogenesis in human lymphomas
Ribatti, D., Tamma, R., Annese, T., Ingravallo, G., & Specchia, G. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-023-01291-y · Cited by 18
“The phenotype of M1–M2 macrophages may be reversed [7, 8].”
BackgroundOct4 activates IL-17A to orchestrate M2 macrophage polarization and cervical cancer metastasis
Bian, Z., Wu, X., Chen, Q., Gao, Q., Xue, X., & Wang, Y. (2024) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03596-z · Cited by 21
“In TME, macrophages under stress can transform into M2 polarized macrophages, take part in the modulation of angiogenesis, and trigger the metastasis of cancer cells [6].”
BackgroundPolarization of M2 Tumor-Associated Macrophages (TAMs) in Cancer Immunotherapy
Bui, I., & Bonavida, B. (2024) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2024053830 · Cited by 20
Lee, S. W., Kim, S., Kim, B., Seong, J. B., Park, Y., Lee, H. J., Choi, D. K., Yeom, E., & Lee, D. (2024) · Molecular Medicine · doi:10.1186/s10020-024-00911-x · Cited by 19
“Activated macrophages are classified into two phenotypes, M1 and M2, based on the expression of surface receptors, secretory factors, and functions (Boutilier and Elsawa 2021).”
BackgroundM1 macrophage-derived exosomal microRNA-29c-3p suppresses aggressiveness of melanoma cells via ENPP2
An, B., Shin, C.-H., Kwon, J. W., Tran, N. L., Kim, A. H., Jeong, H., Kim, S., Park, K., & Oh, S. J. (2024) · Cancer Cell International · doi:10.1186/s12935-024-03512-0 · Cited by 19
“At the same time, M1 macrophages are well known for exerting antitumor effects on various cancers, including melanoma [20].”
BackgroundThe tumor microenvironment of metastatic osteosarcoma in the human and canine lung
McGee, L. E., Pereira, J. D. S., McEachron, T. A., Mazcko, C. N., LeBlanc, A. K., & Beck, J. A. (2025) · Communications Biology · doi:10.1038/s42003-025-07992-2 · Cited by 22
“While M1 macrophages aid in the removal of tumors and activation of anti-tumor CD8 + T cells, M2 macrophages are thought to promote tumor progression through a variety of mechanisms including promotion of angiogenesis and production of cytokines and chemokines 58 – 60 .”
Zhao, D., Zhang, Z., Wang, Z., Du, Z., Wu, M. Y., Zhang, T., Zhou, J., Zhao, W., & Meng, Y. (2022) · Genes · doi:10.3390/genes13060935 · Cited by 18
Guglietta, S., & Krieg, C. (2022) · Blood Reviews · doi:10.1016/j.blre.2022.101012 · Cited by 20
Crosstalk between Tumor-Associated Macrophages and MicroRNAs: A Key Role in Tumor Microenvironment
Zhou, X., Chen, B., Zhang, Z., Huang, Y., Li, J., Wei, Q., Cao, D., & Ai, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113258 · Cited by 19
“TAMs are activated by factors secreted by tumors, and their phenotype depends on the type of tumor entity, and stage of tumor development (primary tumor or metastasis) [52,53].”
BackgroundGonzález‐Callejo, P., Guo, Z., Ziglari, T., Claudio, N., Nguyen, K. H., Oshimori, N., Seras-Franzoso, J., & Pucci, F. (2023) · PLoS ONE · doi:10.1371/journal.pone.0279400 · Cited by 19
“One key functional biomarker of TAM polarization is MHC-II [56].”
Targeting Macrophages for Tumor Therapy
Wang, Y., Barrett, A., & Hu, Q. (2023) · The AAPS Journal · doi:10.1208/s12248-023-00845-y · Cited by 22
“M2-macrophages clear debris and release transforming growth factor-β (TGF-β), platelet-derived growth factor (PDGF), and VEGF to aid in wound healing and repair (90, 91).”
BackgroundTonic signaling in CAR-T therapy: the lever long enough to move the planet
Huang, Y., & Wang, H. (2025) · Frontiers of Medicine · doi:10.1007/s11684-025-1130-x · Cited by 20
Wei, G., Li, X., Huang, M., Wang, H., Li, Z., & Qu, S. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202501123 · Cited by 18
Chen, Y., Qi, Y., Jiang, Y., Li, Y., Yang, S., Wang, L., Li, M., Chai, K., & Wang, Y. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118317 · Cited by 18
Yang, X., Liu, X., Li, J., Zhang, P., Li, H., Chen, G., Zhang, W., Wang, T., Frazer, I. H., & Ni, G. (2022) · Cancers · doi:10.3390/cancers14235785 · Cited by 19
“M2-like MΦs produce high levels of anti-inflammatory cytokines, such as IL-10, which amplifies metabolic pathways that can suppress adaptive immune responses [35].”
BackgroundGong, X., Ma, T., Zhang, Q., Wang, Y., Song, C., Lai, M., Zhang, C., Fang, X., & Chen, X. (2023) · Viruses · doi:10.3390/v15030773 · Cited by 19
“The M1activated macrophages secrete a mixture of pro-inflammatory cytokines (TNF-α, IL-6, and IL-12), inducing a high production of nitric oxide synthase (iNOS) involved in the elimination of pathogens [19,23].”
BackgroundDeciphering the tumour immune microenvironment cell by cell
Nabhan, M., Egan, D., Kreileder, M., Zhernovkov, V., Timosenko, E., Slidel, T. W. F., Dovedi, S. J., Glennon, K., Brennan, D. J., & Kölch, W. (2023) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2023.100383 · Cited by 19
“TAMs are often equated with M2polarized macrophages, which promote tumour growth, metastasis and immune suppression, whereas M1-polarized macrophages are considered anti-tumourigenic.(25) These findings were extended by numerous subsequent surveys of different cancer types.”
BackgroundWang, M.-Q., Zhu, J., Ye, Y.-Q., Li, P., Sun, W.-J., & Zhang, M. (2023) · Aging · doi:10.18632/aging.204868 · Cited by 17
Bradykinin B1 Receptor Affects Tumor-Associated Macrophage Activity and Glioblastoma Progression
Shen, C., Huang, B., Charoensaensuk, V., Yang, L., Tsai, C., Liu, Y.-S., Lu, D., Yeh, W., & Lin, C. (2023) · Antioxidants · doi:10.3390/antiox12081533 · Cited by 19
“Furthermore, chemokines can affect TAM polarization [100].”
Drug resistance mechanism and reversal strategy in lung cancer immunotherapy
Xu, Y., Liu, Y., Ge, Y., Li, H., Zhang, Y., & Wang, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1230824 · Cited by 18
“M1-type macrophages are associated with inflammatory responses and anti-tumor immunity, whereas M2-type macrophages, which resemble TAMs, have pro-tumor properties (Gambardella et al., 2020; Boutilier and Elsawa, 2021).”
BackgroundJia, L., Gao, F., Hu, G., Fang, Y., Tang, L., Wen, Q., Gao, N., Xu, H., & Qiao, H. (2023) · Advanced Science · doi:10.1002/advs.202303975 · Cited by 29
Wei, F., Chen, F., Wu, S., Zha, M., Liu, J., Wong, K., Li, K., & Wong, K. M. (2024) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.3c04350 · Cited by 17
Wu, J., Zhang, Y., Tang, H., & Ye, B. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00731 · Cited by 17
Wu, D., Gong, T., Sun, Z., Yao, X., Wang, D., Chen, Q., Guo, Q., Li, X., Guo, Y., & Lu, Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.131826 · Cited by 19
Sinkarevs, S., Štrumfs, B., Volkova, S., & Štrumfa, I. (2024) · Cells · doi:10.3390/cells13121057 · Cited by 22
“Polarisation towards the M2 phenotype is usually induced by the presence of Th2 cells producing interleukins 13 (IL-13) and 4 (IL-4), as well as enhanced expression of colony-stimulating factor 1 receptor (CSF1R) on the surface of a macrophage [21].”
BackgroundRevealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progression
Jiang, Z., Kang, Q., Qian, H., Xu, Z., Tong, H., Yang, J., Li, L., Li, R., Li, G., Chen, F., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01912-2 · Cited by 17
“These interactions involved signaling pathways associated with macrophage M2 polarization, which is known to support tumor proliferation, 66 as well as pathways like EGF and PDGF signaling that promote tumor cell proliferation and survival.”
BackgroundRuze, R., Chen, Y., Song, J., Xu, R., Yin, X., Xu, Q., Wang, C., & Zhao, Y. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217162 · Cited by 20
Muteeb, G., Khafaga, D. S. R., El-Morsy, M. T., Farhan, M., Aatif, M., & Hosney, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37217 · Cited by 17
“TAMs predominantly exhibit an M2 phenotype, often referred to as pro-tumor, as they facilitate cancer cell proliferation, angiogenesis, and metastasis through distinct anti-inflammatory mechanisms [48,49] as illustrated in Fig.”
BackgroundReprogramming tumor-associated macrophages using exosomes from M1 macrophages
Mahmoudi, M., Taghavi-Farahabadi, M., Hashemi, S. M., Mousavizadeh, K., Rezaei, N., & Mojtabavi, N. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150697 · Cited by 18
Yoshimura, K., Zou, G., Fan, Y., Yamashita, K., Wang, L., Wu, J., Wang, R., Shao, S., Scott, A. W., Jin, J., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217354 · Cited by 20
Zhou, F., Tao, J., Gou, H., Liu, S., Dong, Y., Zhang, J., Ji, J., Lin, N., & Wang, Y. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217400 · Cited by 17
Moura, T., Caramelo, O. L., Silva, I., Silva, S., Gonçalo, M., Portilha, M. A., Moreira, J. N., Gil, A. M., Laranjeira, P., & Paiva, A. A. (2025) · Biomolecules · doi:10.3390/biom15010078 · Cited by 19
Gemcitabine: immunomodulatory or immunosuppressive role in the tumor microenvironment
Nemati, M., Hsu, C., Nathiya, D., Kumar, M., Oghenemaro, E. F., Kariem, M., Kaur, P., Bhanot, D., Hjazi, A. M., & Saedi, T. A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1536428 · Cited by 20
Wang, W., Zhao, R., Wang, Y., Pan, L., Luan, F., & Fu, G. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1602752 · Cited by 19
Xu, L., Wang, L., Yang, R., Li, T., & Zhu, X. (2023) · Human Molecular Genetics · doi:10.1093/hmg/ddad052 · Cited by 19
Ozaniak, A., Smetanová, J., Bartolini, R., Rataj, M., Čapková, L., Háček, J., Fialová, M., Krupickova, L., Stříž, I., Lischke, R., et al. (2022) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-022-04292-8 · Cited by 17
“This therapy-induced activation of macrophages may also promote cytokine release by tumor-associated macrophages which are the most prevalent macrophage subtype in the TME (Boutilier and Elsawa 2021).”
BackgroundApelin triggers macrophage polarization to M2 type in head and neck cancer
Celik, F. S., Güneş, C. E., Yavuz, E., & Kurar, E. (2023) · Immunobiology · doi:10.1016/j.imbio.2023.152353 · Cited by 17
Lentinan regulates the immune efficacy of macrophage for lung metastasis in triple negative breast
Guan, Z., Liu, Y., Liu, P., Yin, L., Chen, L., & Duan, W. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105560 · Cited by 19
Gelbach, P. E., & Finley, S. D. (2023) · iScience · doi:10.1016/j.isci.2023.107569 · Cited by 16
“oxidative phosphorylation and are oriented toward the production of urea and polyamines, which are used as mediators of wound healing.(13,21,22)”
Vámos, E., Kálmán, N., Sturm, E. M., Nayak, B. B., Teppan, J., Vántus, V. B., Kovács, D., Makszin, L., Lóránd, T., Gallyas, F., et al. (2023) · Antioxidants · doi:10.3390/antiox12101790 · Cited by 16
“We equally determined ROS, nitrite and TNF-α production in IFN-γ -induced RAW264.”
BackgroundInfluentialZhao, Z., Xue, Y., Yang, J., Qin, H., & Yang, X. (2023) · Applied Physics Letters · doi:10.1063/5.0169506 · Cited by 16
Liu, B., Huang, J., Xiao, J., Xu, W., Zhang, H., Yuan, Y., Yin, Y., & Zhang, X. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01153-w · Cited by 16
“In contrast, M2 macrophages promote tumor development via proangiogenic factors and immunosuppressive cytokines like TGF-β and IL-10 [21].”
BackgroundFBXW7 and human tumors: mechanisms of drug resistance and potential therapeutic strategies
Wang, W., Jiang, K., Liu, X., Li, J., Zhou, W., Wang, C., Cui, J., & Liang, T. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1278056 · Cited by 17
“M2-polarized macrophages participate in cancer initiation, development and metastasis by improving the invasive properties of tumor cells, immune suppression, hypoxia induction, angiogenic and lymphangiogenic regulation (Hughes et al., 2015; Boutilier and Elsawa, 2021).”
BackgroundChen, P., Xiong, F., Pu, X., Hu, Z., Yang, Y., Qiao, X., Jiang, Y., Han, M., Wang, D., & Li, X. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1326031 · Cited by 16
“M1 macrophages are capable of killing tumor cells and recognizing foreign antigens, while M2 macrophages produce immunosuppressive factors in the tumor microenvironment, acting as suppressors of the immune response (58).”
BackgroundHuang, W., Jiang, M., Lin, Y., Qi, Y., & Li, B. (2024) · Discover Oncology · doi:10.1007/s12672-024-00972-8 · Cited by 16
“Tumor-associated macrophages (TAMs), the largest population of immune cells in the TIM, display two major phenotypes, M1 and M2 [5].”
BackgroundMulti-Drug Resistance and Breast Cancer Progression via Toll-Like Receptors (TLRs) Signaling
Pallathadka, H., Khaleel, A. Q., Zwamel, A. H., Malathi, H., Sharma, S., Rizaev, J. A., Mustafa, Y. F., Pramanik, A., Alubiady, M. H. S., & Jawad, M. A. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01418-2 · Cited by 16
“Speci fi c chemokines are able, in fact, to connect to more than one receptor (CCL5, for instance, connects to CCR1, CCR3, and CCR5), or the same chemokine receptor may attach to more than one ligand (CCR5, for example, connects to both CCL3 and CCL5) [54, 65, 66].”
Zhang, X., Guo, L., Tian, W., Yang, Y., Yin, Y., Qiu, Y., Wang, W., Li, Y., Zhang, G., Zhao, X., et al. (2024) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-23-1047 · Cited by 18
Jing, M., Ma, M., Zhang, M., Mei, Y., Wang, L., Jiang, Y., Li, J., Song, R., Yang, Z., Pu, Y., et al. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.155023 · Cited by 17
Duan, X., Xiong, Y., & Gan, J. (2024) · Cancer Biology & Therapy · doi:10.1080/15384047.2024.2424490 · Cited by 18
Wang, Y., Wang, X. W., Liu, Y., Xu, J., Zhu, J., Zheng, Y., & Quan, Q. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1467052 · Cited by 23
“…by reducing in fi ltration and function of CD8+ T cells, impairing maturation and activities of dendritic cells coupled with natural killer cells, evoking M2-like polarization of tumor-associated macrophages, and boosting regulatory T cells and myeloid-derived suppressor cells activities (25, 26).”
Ge, Y., Jiang, L., Yang, C., Dong, Q., Tang, C., Xu, Y., & Zhong, X. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1449696 · Cited by 17
“In recent years, several macrophage subtypes distinct from the traditional M1/M2 classi fi cation have been identi fi ed, including CD169+, STAT1+, LYVE1+, SPP1+, CXCL10+, and FOLR2+ macrophages, as well as regulatory macrophages (26, 39, 40).”
Baek, S., Sung, E., Kim, G., Hong, M. H., Lee, C. Y., Shim, H. S., Park, S. Y., Kim, H. R., & Lee, I. (2025) · 癌症:英文版 · doi:10.1002/cac2.12658 · Cited by 17
Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients
Martín-Carrasco, C., Delgado-Bonet, P., Tomeo-Martín, B. D., Pastor, J., de la Riva, C., Palau-Concejo, P., del Castillo, N., Garcı́a-Castro, J., & Perisé-Barrios, A. J. (2022) · Veterinary Sciences · doi:10.3390/vetsci9070327 · Cited by 16
“MAC387 has been identified as a marker for macrophages with an M1-like phenotype, usually associated with a pro-inflammatory and immunosuppressive TME, that favors an antitumoral response [56,57].”
BackgroundTumor cell-derived asymmetric dimethylarginine regulates macrophage functions and polarization
Chen, Y., Lowery, A. T., Lin, S., Walker, A. M., & Chen, K. E. (2022) · Cancer Cell International · doi:10.1186/s12935-022-02769-7 · Cited by 20
“At the other extreme, the M2 macrophages secrete factors that promote tumor growth, angiogenesis, and metastasis [14, 15].”
BackgroundAdvances in chimeric antigen receptor T cells therapy in the treatment of breast cancer
He, Q., Hu, H., Yang, F., Song, D. E., Zhang, X., & Dai, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114609 · Cited by 16
Hsu, S., Jadhao, M., Liao, W., Chang, W., Lin, I., & Chiu, C. (2023) · Cancers · doi:10.3390/cancers15061776 · Cited by 18
“The former has proinflammatory and antitumor effects and functions in tissue damage, while the latter has anti-inflammatory and protumor effects and participates in tissue repair [69,70].”
BackgroundXu, J., Zou, J., Zhang, D., Zhang, K., Qi, Y., Yan, C., Lee, E., Jia, Q., Ma, C., & Jiang, H. B. (2025) · Progress in Materials Science · doi:10.1016/j.pmatsci.2025.101541 · Cited by 16
Shi, J., Ma, Q., Su, W., Liu, C., Zhang, H., Liu, Y., Li, X., Jiang, X., Ge, C., Kong, F., et al. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00390-x · Cited by 19
“So far, no direct evidence has yet confirmed whether the polarization of M1 TAMs or enhanced calcium ions influx leads to the activation of the TME.”
BackgroundInfluentialLncRNA/CircRNA-miRNA-mRNA Axis in Atherosclerotic Inflammation: Research Progress
Lv, N., Zhang, Y., Wang, L., Suo, Y., Zeng, W., Yu, Q., Yu, B., & Jiang, X. (2023) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010267577231005102901 · Cited by 16
Spatial immune composition of tumor microenvironment in patients with pancreatic cancer
Zwart, E. S., van Ee, T., Affandi, A. J., Boyd, L. N. C., Rodríguez, E., den Haan, J. M. M., Sarasqueta, A. F., van Grieken, N. C. T., Meijer, L. L., van Kooyk, Y., et al. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03573-6 · Cited by 16
“These cytokines inhibit pro-inflammatory cells such as cytotoxic CD8 + T cells and DCs, but also push naïve T cells to differentiate into regulatory T cells [22, 23].”
BackgroundA metabolic perspective on nitric oxide function in melanoma
Jimenez, J., Dubey, P., Carter, B., Koomen, J. M., & Markowitz, J. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189038 · Cited by 17
Aggarwal, A., Khalighi, S., Babu, D., Li, H., Azarianpour, S., Corredor, G., Fu, P., Mokhtari, M., Pathak, T. B., Thayer, E. G., et al. (2024) · Communications Medicine · doi:10.1038/s43856-023-00428-0 · Cited by 16
“M1 macrophages contribute to ECM degradation and bolster an anti-tumor immune response, whereas M2 macrophages promote ECM remodeling that facilitates tumor progression 36 .”
Ni, J., Xi, X., Xiao, S., & Xiao, X. (2024) · Molecular Biotechnology · doi:10.1007/s12033-023-01034-0 · Cited by 15
“Macrophages are a major immune population that makes up the TME and an essential factor in establishing the inflammatory TME associated with tumor cell growth and metastasis [5].”
New Strategies for Macrophage Re-Education in Cancer: An Update
Lampiasi, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063414 · Cited by 15
“Unfortunately, tumor cells have learned to take advantage of these repair mechanisms and exploit these mechanisms for their benefit [7].”
BackgroundWang, M., Cai, R., Zhang, Z., Feng, L., Lei, Z., Wang, F., Yu, Z., Liu, L., Yang, X., Guo, H., et al. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02568-4 · Cited by 17
“M1 macrophages secrete cytokines such as IL-12 and IL-23 that play roles in antigen presentation, activation of the immune response, and inhibition of tumor progression [33].”
BackgroundLu, Y., Zhu, W., Zhang, G., Chen, J., Wang, Q. L., Mao, M. Y., Deng, S. C., Jin, L. P., Liu, H., & Kuang, Y. H. (2024) · Clinical Immunology · doi:10.1016/j.clim.2024.110309 · Cited by 16
Sun, H., Wang, X., Guo, Z., Hu, Z., Yin, Y., Duan, S., Jia, W., Lü, W., & Hu, J. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s459400 · Cited by 15
Metadata
- Authors
- Boutilier, A. J., & Elsawa, S. F.
- Affiliations
- University of New Hampshire (US)
- Corresponding author
- Elsawa, Sherine F.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-29
- Volume
- 22
- Issue
- 13
- Pages
- 6995
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8268869
- OpenAlex
- W3173665490
- Cited by
- 1,631
- References
- 148
- Citations by year
- 2026: 281 · 2025: 409 · 2024: 429 · 2023: 359 · 2022: 144 · 2021: 9
- FWCI
- 24.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (P20 GM113131)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Keywords
- macrophage polarization, tumor-associated macrophages, tumor microenvironment, tumor progression, angiogenesis, lymphangiogenesis, immunosuppression, hypoxia, metastasis, macrophage recruitment
- MeSH terms
- Tumor-Associated Macrophages, Animals, Hypoxia, Cell Transformation, Neoplastic, Humans, Inflammation, Macrophage Activation, Neoplasm Metastasis, Neoplasm Staging, Signal Transduction, Biomarkers, Immunophenotyping, Cytokines, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.